149 related articles for article (PubMed ID: 15899813)
1. Functional epigenomics identifies genes frequently silenced in prostate cancer.
Lodygin D; Epanchintsev A; Menssen A; Diebold J; Hermeking H
Cancer Res; 2005 May; 65(10):4218-27. PubMed ID: 15899813
[TBL] [Abstract][Full Text] [Related]
2. Survey of differentially methylated promoters in prostate cancer cell lines.
Wang Y; Yu Q; Cho AH; Rondeau G; Welsh J; Adamson E; Mercola D; McClelland M
Neoplasia; 2005 Aug; 7(8):748-60. PubMed ID: 16207477
[TBL] [Abstract][Full Text] [Related]
3. Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.
Schulz WA; Alexa A; Jung V; Hader C; Hoffmann MJ; Yamanaka M; Fritzsche S; Wlazlinski A; Müller M; Lengauer T; Engers R; Florl AR; Wullich B; Rahnenführer J
Mol Cancer; 2007 Feb; 6():14. PubMed ID: 17280610
[TBL] [Abstract][Full Text] [Related]
4. Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis.
Kamdar SN; Ho LT; Kron KJ; Isserlin R; van der Kwast T; Zlotta AR; Fleshner NE; Bader G; Bapat B
Clin Epigenetics; 2016; 8():32. PubMed ID: 26981160
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix-based gene signature for predicting prognosis in colon cancer and immune microenvironment.
Chai R; Su Z; Zhao Y; Liang W
Transl Cancer Res; 2023 Feb; 12(2):321-339. PubMed ID: 36915600
[TBL] [Abstract][Full Text] [Related]
6. HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt/β-catenin signaling pathway during the progression of HCC.
Wang X; Zhou Y; Wang C; Zhao Y; Cheng Y; Yu S; Li X; Zhang W; Zhang Y; Quan H
Clin Transl Oncol; 2022 Oct; 24(10):1998-2009. PubMed ID: 35768685
[TBL] [Abstract][Full Text] [Related]
7. High expression of 14-3-3ơ indicates poor prognosis and progression of lung adenocarcinoma.
Feng J; Leng J; Zhao C; Guo J; Chen Y; Li H
Oncol Lett; 2022 Jul; 24(1):203. PubMed ID: 35720477
[TBL] [Abstract][Full Text] [Related]
8. The Expression of Proto-Oncogene
Khosh Kish E; Choudhry M; Gamallat Y; Buharideen SM; D D; Bismar TA
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563163
[TBL] [Abstract][Full Text] [Related]
9. Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma.
Stubbe BE; Henriksen SD; Madsen PH; Larsen AC; Krarup HB; Pedersen IS; Johansen MN; Thorlacius-Ussing O
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830873
[TBL] [Abstract][Full Text] [Related]
10. SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo.
Cruz-Hernández CD; Cruz-Burgos M; Cortés-Ramírez SA; Losada-García A; Camacho-Arroyo I; García-López P; Langley E; González-Covarrubias V; Llaguno-Munive M; Albino-Sánchez ME; Cruz-Colín JL; Pérez-Plasencia C; Beltrán-Anaya FO; Rodríguez-Dorantes M
Cancer Cell Int; 2020; 20():312. PubMed ID: 32694934
[TBL] [Abstract][Full Text] [Related]
11. Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention.
Izzo S; Naponelli V; Bettuzzi S
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32268584
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
[TBL] [Abstract][Full Text] [Related]
13. Prostate Cancer Energetics and Biosynthesis.
Lin C; Salzillo TC; Bader DA; Wilkenfeld SR; Awad D; Pulliam TL; Dutta P; Pudakalakatti S; Titus M; McGuire SE; Bhattacharya PK; Frigo DE
Adv Exp Med Biol; 2019; 1210():185-237. PubMed ID: 31900911
[TBL] [Abstract][Full Text] [Related]
14. Dickkopf Homolog 3
Gondkar K; Patel K; Patil Okaly GV; Nair B; Pandey A; Gowda H; Kumar P
Front Oncol; 2019; 9():1121. PubMed ID: 31737564
[TBL] [Abstract][Full Text] [Related]
15. Differential gene methylation patterns in cancerous and non‑cancerous cells.
Kamińska K; Białkowska A; Kowalewski J; Huang S; Lewandowska MA
Oncol Rep; 2019 Jul; 42(1):43-54. PubMed ID: 31115550
[TBL] [Abstract][Full Text] [Related]
16. Troglitazone inhibits the migration and invasion of PC-3 human prostate cancer cells by upregulating E-cadherin and glutathione peroxidase 3.
Chang SN; Lee JM; Oh H; Kim U; Ryu B; Park JH
Oncol Lett; 2018 Oct; 16(4):5482-5488. PubMed ID: 30250621
[TBL] [Abstract][Full Text] [Related]
17. ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.
Tungekar A; Mandarthi S; Mandaviya PR; Gadekar VP; Tantry A; Kotian S; Reddy J; Prabha D; Bhat S; Sahay S; Mascarenhas R; Badkillaya RR; Nagasampige MK; Yelnadu M; Pawar H; Hebbar P; Kashyap MK
Sci Rep; 2018 Aug; 8(1):12715. PubMed ID: 30143675
[TBL] [Abstract][Full Text] [Related]
18. Differential Expression of Coding and Long Noncoding RNAs in Keratoconus-Affected Corneas.
Khaled ML; Bykhovskaya Y; Yablonski SER; Li H; Drewry MD; Aboobakar IF; Estes A; Gao XR; Stamer WD; Xu H; Allingham RR; Hauser MA; Rabinowitz YS; Liu Y
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2717-2728. PubMed ID: 29860458
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Mediated Reactivation of DKK3 Expression Attenuates TGF-β Signaling in Prostate Cancer.
Kardooni H; Gonzalez-Gualda E; Stylianakis E; Saffaran S; Waxman J; Kypta RM
Cancers (Basel); 2018 May; 10(6):. PubMed ID: 29843383
[TBL] [Abstract][Full Text] [Related]
20. Dickkopf-3 Upregulates VEGF in Cultured Human Endothelial Cells by Activating Activin Receptor-Like Kinase 1 (ALK1) Pathway.
Busceti CL; Marchitti S; Bianchi F; Di Pietro P; Riozzi B; Stanzione R; Cannella M; Battaglia G; Bruno V; Volpe M; Fornai F; Nicoletti F; Rubattu S
Front Pharmacol; 2017; 8():111. PubMed ID: 28352232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
